title: Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer.
abstract: OBJECTIVE
  Fatigue is the most common and often the most bothersome complaint of individuals who are treated for cancer. One intervention now commonly suggested to treat fatigue is the use of psychostimulant medication. Early studies indicate some success in individuals with a mixed cancer diagnoses. This study evaluates the effect of methylphenidate on fatigue in women with recurrent gynecologic cancer.
  
  
  METHODS
  Thirty-two women treated for recurrent gynecologic cancer were prescribed methylphenidate at morning and noon over a 8-week period. Participants completed the Fatigue Symptom Inventory (FSI) along with assessments of quality of life and mood at baseline, week 2, 4 and 8 to determine changes in levels of fatigue experienced.
  
  
  RESULTS
  Patients reported significant declines in fatigue (p=0.0001), and improvement in both mood (p=0.0020) and quality of life (p=0.0351) when comparing baseline scores to study end.
  
  
  CONCLUSIONS
  This study provides support for the use of a psychostimulant to treat fatigue in women who have recurrent gynecologic cancer. It is particularly relevant for these patients with incurable disease who are facing the end of life.
authors.affiliation: Southern Illinois University School of Medicine, Division of Psycho-Oncology, Springfield, Illinois 62794-9642, USA. rjohnson@siumed.edu
authors.forename: Rhonda L
authors.initials: RL
authors.lastname: Johnson
authors.forename: Ingrid
authors.initials: I
authors.lastname: Block
authors.forename: Michael A
authors.initials: MA
authors.lastname: Gold
authors.forename: Stephen
authors.initials: S
authors.lastname: Markwell
authors.forename: Melanie
authors.initials: M
authors.lastname: Zupancic
mesh_terms: D000328:Adult; D000339:Affect; D000368:Aged; D000369:Aged, 80 and over; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D005221:Fatigue / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D005260:Female; D005833:Genital Neoplasms, Female / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010865:Pilot Projects; D011788:Quality of Life; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate